NEFECON(R) Receives NMPA Approval for Production Expansion in China,as Everest Medicines Accelerates Accessibility and Capacity Efforts
HONG KONG, Aug 5, 2025 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK) today announced that the supplemental application for the